80 related articles for article (PubMed ID: 24236052)
1. MDM2 promotes invasion and metastasis in invasive ductal breast carcinoma by inducing matrix metalloproteinase-9.
Chen X; Qiu J; Yang D; Lu J; Yan C; Zha X; Yin Y
PLoS One; 2013; 8(11):e78794. PubMed ID: 24236052
[TBL] [Abstract][Full Text] [Related]
2. GATA4 regulates the transcription of MMP9 to suppress the invasion and migration of breast cancer cells via HDAC1-mediated p65 deacetylation.
Yang Y; Song S; Li S; Kang J; Li Y; Zhao N; Ye D; Qin F; Du Y; Sun J; Yu T; Wu H
Cell Death Dis; 2024 Apr; 15(4):289. PubMed ID: 38653973
[TBL] [Abstract][Full Text] [Related]
3. Mycotoxin source and its exposure causing mycotoxicoses.
Nawaf A
Bioinformation; 2023; 19(4):348-357. PubMed ID: 37822835
[TBL] [Abstract][Full Text] [Related]
4. Updating the therapeutic role of ginsenosides in breast cancer: a bibliometrics study to an in-depth review.
Deng X; Wang J; Lu C; Zhou Y; Shen L; Ge A; Fan H; Liu L
Front Pharmacol; 2023; 14():1226629. PubMed ID: 37818185
[TBL] [Abstract][Full Text] [Related]
5. Functional role and epithelial to mesenchymal transition of the miR-590-3p/MDM2 axis in hepatocellular carcinoma.
Youssef AI; Khaled GM; Amleh A
BMC Cancer; 2023 May; 23(1):396. PubMed ID: 37138218
[TBL] [Abstract][Full Text] [Related]
6. MDM2 and MDMX promote ferroptosis by PPARα-mediated lipid remodeling.
Venkatesh D; O'Brien NA; Zandkarimi F; Tong DR; Stokes ME; Dunn DE; Kengmana ES; Aron AT; Klein AM; Csuka JM; Moon SH; Conrad M; Chang CJ; Lo DC; D'Alessandro A; Prives C; Stockwell BR
Genes Dev; 2020 Apr; 34(7-8):526-543. PubMed ID: 32079652
[TBL] [Abstract][Full Text] [Related]
7. SCF
Bai J; Wu K; Cao MH; Yang Y; Pan Y; Liu H; He Y; Itahana Y; Huang L; Zheng JN; Pan ZQ
Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11754-11763. PubMed ID: 31138683
[TBL] [Abstract][Full Text] [Related]
8. Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells.
Gao C; Xiao G; Piersigilli A; Gou J; Ogunwobi O; Bargonetti J
Breast Cancer Res; 2019 Jan; 21(1):5. PubMed ID: 30642351
[TBL] [Abstract][Full Text] [Related]
9. MDM2 Overexpression Modulates the Angiogenesis-Related Gene Expression Profile of Prostate Cancer Cells.
Venkatesan T; Alaseem A; Chinnaiyan A; Dhandayuthapani S; Kanagasabai T; Alhazzani K; Dondapati P; Alobid S; Natarajan U; Schwartz R; Rathinavelu A
Cells; 2018 May; 7(5):. PubMed ID: 29748481
[TBL] [Abstract][Full Text] [Related]
10. Effects of disodium cantharidinate on dendritic cells of patients with bladder carcinoma.
Zang GH; Li R; Zhou RS; Hao L; He HG; Zhang WD; Dong Y; Han CH
Oncol Lett; 2018 Feb; 15(2):2273-2277. PubMed ID: 29434934
[TBL] [Abstract][Full Text] [Related]
11. MEG3 inhibits proliferation and invasion and promotes apoptosis of human osteosarcoma cells.
Shi Y; Lv C; Shi L; Tu G
Oncol Lett; 2018 Feb; 15(2):1917-1923. PubMed ID: 29434890
[TBL] [Abstract][Full Text] [Related]
12. Murine double minute 2, a potential p53-independent regulator of liver cancer metastasis.
Ranjan A; Bera K; Iwakuma T
Hepatoma Res; 2016; 2():114-121. PubMed ID: 28944296
[TBL] [Abstract][Full Text] [Related]
13. Early-Stage Metastasis Requires Mdm2 and Not p53 Gain of Function.
Hauck PM; Wolf ER; Olivos DJ; Batuello CN; McElyea KC; McAtarsney CP; Cournoyer RM; Sandusky GE; Mayo LD
Mol Cancer Res; 2017 Nov; 15(11):1598-1607. PubMed ID: 28784612
[TBL] [Abstract][Full Text] [Related]
14. S100P is associated with proliferation and migration in nasopharyngeal carcinoma.
Liu Y; Wang C; Shan X; Wu J; Liu H; Liu H; Zhang J; Xu W; Sha Z; He J; Fan J
Oncol Lett; 2017 Jul; 14(1):525-532. PubMed ID: 28693201
[TBL] [Abstract][Full Text] [Related]
15. The role of MDM2 and MDM4 in breast cancer development and prevention.
Haupt S; Vijayakumaran R; Miranda PJ; Burgess A; Lim E; Haupt Y
J Mol Cell Biol; 2017 Feb; 9(1):53-61. PubMed ID: 28096293
[TBL] [Abstract][Full Text] [Related]
16. Serum anti-MDM2 and anti-c-Myc autoantibodies as biomarkers in the early detection of lung cancer.
Li P; Shi JX; Dai LP; Chai YR; Zhang HF; Kankonde M; Kankonde P; Yu BF; Zhang JY
Oncoimmunology; 2016 May; 5(5):e1138200. PubMed ID: 27467958
[TBL] [Abstract][Full Text] [Related]
17. Mouse double minute 2 (MDM2) upregulates Snail expression and induces epithelial-to-mesenchymal transition in breast cancer cells in vitro and in vivo.
Lu X; Yan C; Huang Y; Shi D; Fu Z; Qiu J; Yin Y
Oncotarget; 2016 Jun; 7(24):37177-37191. PubMed ID: 27184007
[TBL] [Abstract][Full Text] [Related]
18. Interference with mutagenic aflatoxin B1-induced checkpoints through antagonistic action of ochratoxin A in intestinal cancer cells: a molecular explanation on potential risk of crosstalk between carcinogens.
Kim J; Park SH; Do KH; Kim D; Moon Y
Oncotarget; 2016 Jun; 7(26):39627-39639. PubMed ID: 27119350
[TBL] [Abstract][Full Text] [Related]
19. Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy.
Qin JJ; Wang W; Sarkar S; Voruganti S; Agarwal R; Zhang R
Oncotarget; 2016 May; 7(22):32566-78. PubMed ID: 27105525
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil MiRNA-128-3p is Decreased During Active Phase of Granulo-matosis with Polyangiitis.
Surmiak M; Hubalewska-Mazgaj M; Wawrzycka-Adamczyk K; Musiał J; Sanak M
Curr Genomics; 2015 Oct; 16(5):359-65. PubMed ID: 27047256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
